Method of efficiently establishing induced pluripotent stem cells

US8993329B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8993329-B2
Application numberUS-201013393158-A
CountryUS
Kind codeB2
Filing dateSep 22, 2010
Priority dateSep 24, 2009
Publication dateMar 31, 2015
Grant dateMar 31, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a method of improving iPS cell establishment efficiency, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B to a somatic cell, particularly to a somatic cell on which Lin28 is ineffective or less effective than Lin28B in improving iPS cell establishment efficiency, and a method of producing an iPS cell, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B and a nuclear reprogramming substance to a somatic cell. Also provided are an iPS cell comprising a nucleic acid that encodes Lin28B, that can be obtained by the method of producing an iPS cell, and a method of somatic cell production by forcing the iPS cell to differentiate into a somatic cell.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of improving induced pluripotent stem (iPS) cell establishment efficiency, comprising transferring Lin28B or a nucleic acid that encodes Lin28B to a somatic cell undergoing nuclear reprogramming, wherein the nuclear reprogramming is brought about by contacting the somatic cells with nuclear reprogramming substances comprising (a) Oct3/4 or a nucleic acid that encodes Oct3/4, (b) Sox2 or a nucleic acid that encodes Sox2, and (c) Klf4 or a nuclei…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8993329B2 cover?
Provided are a method of improving iPS cell establishment efficiency, comprising the step of transferring Lin28B or a nucleic acid that encodes Lin28B to a somatic cell, particularly to a somatic cell on which Lin28 is ineffective or less effective than Lin28B in improving iPS cell establishment efficiency, and a method of producing an iPS cell, comprising the step of transferring Lin28B or a n…
Who is the assignee on this patent?
Yamanaka Shinya, Tanabe Koji, Univ Kyoto
What technology area does this patent fall under?
Primary CPC classification C12N5/0696. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).